Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Ernsting

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biomaterials|February 29, 2012
Tumor-targeted drug delivery using MR-contrasted docetaxel - carboxymethylcellulose nanoparticlesMark J Ernsting, Warren D Foltz, Elijus Undzys, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|March 22, 2014
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelAniruddha Roy, Mousumi Bhattacharyya, Mark J Ernsting, et al.
Biomaterials|July 5, 2005
Generation of cell adhesive substrates using peptide fluoralkyl surface modifiersMark J Ernsting, Geneviève C Bonin, Meilin Yang, et al.
Molecular Pharmaceutics|February 26, 2014
Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistanceAniruddha Roy, Mami Murakami, Mark J Ernsting, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 13, 2012
A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastasesMark J Ernsting, Mami Murakami, Elijus Undzys, et al.
Biomaterials|May 10, 2015
Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismBryan Hoang, Mark J Ernsting, Aniruddha Roy, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2010
Bioactivation of porous polyurethane scaffolds using fluorinated RGD surface modifiersPatrick H Blit, Yi Hao Shen, Mark J Ernsting, et al.
Cancer Research|August 3, 2013
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasisMami Murakami, Mark J Ernsting, Elijus Undzys, et al.
Molecular Pharmaceutics|September 26, 2017
Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and CabazitaxelJoseph Bteich, Simon A McManus, Mark J Ernsting, et al.
Cancer Letters|October 3, 2017
Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancerBryan Hoang, Mark J Ernsting, Wei-Hsin Sophia Tang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biomaterials|February 29, 2012
Tumor-targeted drug delivery using MR-contrasted docetaxel - carboxymethylcellulose nanoparticlesMark J Ernsting, Warren D Foltz, Elijus Undzys, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|March 22, 2014
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelAniruddha Roy, Mousumi Bhattacharyya, Mark J Ernsting, et al.
Biomaterials|July 5, 2005
Generation of cell adhesive substrates using peptide fluoralkyl surface modifiersMark J Ernsting, Geneviève C Bonin, Meilin Yang, et al.
Molecular Pharmaceutics|February 26, 2014
Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistanceAniruddha Roy, Mami Murakami, Mark J Ernsting, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 13, 2012
A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastasesMark J Ernsting, Mami Murakami, Elijus Undzys, et al.
Biomaterials|May 10, 2015
Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismBryan Hoang, Mark J Ernsting, Aniruddha Roy, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2010
Bioactivation of porous polyurethane scaffolds using fluorinated RGD surface modifiersPatrick H Blit, Yi Hao Shen, Mark J Ernsting, et al.
Cancer Research|August 3, 2013
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasisMami Murakami, Mark J Ernsting, Elijus Undzys, et al.
Molecular Pharmaceutics|September 26, 2017
Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and CabazitaxelJoseph Bteich, Simon A McManus, Mark J Ernsting, et al.
Cancer Letters|October 3, 2017
Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancerBryan Hoang, Mark J Ernsting, Wei-Hsin Sophia Tang, et al.
Pageof 3